International Journal of Molecular Sciences · 2018 · 79 citations · 30 references
Life SciencesMolecular BiologyNeuroscienceGene ExpressionMolecular NeurobiologyMolecular NeuroscienceCyclin-dependent KinasesMicrorna BiologyMicrorna-mediated RegulationMrna StabilityNoncoding Rna BiologyNoncoding Rna FunctionLong Non-coding Ribonucleic AcidsLong Non-coding Rna FunctionLong Noncoding Rna RegulationMicrorna Dysregulation In DiseaseMicrorna In DevelopmentMrna Stability ControlNoncoding Rna RegulationRegulators
Cyclin-dependent kinase 5 regulatory subunit 1 (CDK5R1) gene encodes for p35, the main activator of Cyclin-dependent kinase 5 (CDK5). The active p35/CDK5 complex is involved in numerous aspects of brain development and function, and its deregulation is closely associated to Alzheimer’s disease (AD) onset and progression. We recently showed that miR-15/107 family can negatively regulate CDK5R1 expression modifying mRNA stability. Interestingly, miRNAs belonging to miR-15/107 family are downregulated in AD brain while CDK5R1 is upregulated. Long non-coding RNAs (lncRNAs) are emerging as master regulators of gene expression, including miRNAs, and their dysregulation has been implicated in the pathogenesis of AD. Here, we evaluated the existence of an additional layer of CDK5R1 expression regulation provided by lncRNAs. In particular, we focused on three lncRNAs potentially regulating CDK5R1 expression levels, based on existing data: NEAT1, HOTAIR, and MALAT1. We demonstrated that NEAT1 and HOTAIR negatively regulate CDK5R1 mRNA levels, while MALAT1 has a positive effect. We also showed that all three lncRNAs positively control miR-15/107 family of miRNAs. Moreover, we evaluated the expression of NEAT1, HOTAIR, and MALAT1 in AD and control brain tissues. Interestingly, NEAT1 displayed increased expression levels in temporal cortex and hippocampus of AD patients. Interestingly, we observed a strong positive correlation between CDK5R1 and NEAT1 expression levels in brain tissues, suggesting a possible neuroprotective role of NEAT1 in AD to compensate for increased CDK5R1 levels. Overall, our work provides evidence of another level of CDK5R1 expression regulation mediated by lncRNAs and points to NEAT1 as a biomarker, as well as a potential pharmacological target for AD therapy.
30
Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes
Miao-Chih Tsai, Ohad Manor, Yue Wan et al. · Science · 2010 · 3.3K citations · Full text
Alzheimer disease in the United States (2010–2050) estimated using the 2010 census
Liesi E. Hebert, Jennifer Weuve, Paul A. Scherr et al. · Neurology · 2013 · 2.7K citations · Full text
Characterizing the RNA targets and position-dependent splicing regulation by TDP-43
James Tollervey, Tomaž Curk, Boris Rogelj et al. · Nature Neuroscience · 2011 · 1.2K citations · Full text